ArticleFrontiers in immunology2025

Artemisinin derivatives modulate KEAP1-NRF2-xCT pathway to alleviate Sjögren's disease: insights from scRNA-seq and systems biology.

Yong Luo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.